Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
5-(4-methoxyphenoxy)-2,4-quinazolinediamine
- Development stage
- Preclinical
- Modality
- Small Molecules
01
Overview
5-(4-methoxyphenoxy)-2,4-quinazolinediamine is a synthetic small molecule belonging to the quinazoline class. It has been primarily studied as an experimental compound and discovery agent rather than a marketed pharmaceutical. The compound acts as an inhibitor of dihydrofolate reductase (DHFR), a key enzyme in folate metabolism that is essential for DNA precursor synthesis and cell proliferation. By inhibiting DHFR, it disrupts nucleotide biosynthesis pathways critical for rapidly dividing cells. This mechanism suggests potential applications in cancer therapy and antimicrobial research; however, there are no approved indications or advanced clinical trials reported for this molecule[1][3][5][7]. Its development status remains investigational.
- Other names
- 5-(4-METHOXYPHENOXY)-2,4-QUINAZOLINEDIAMINE5-(4-methoxyphenoxy)quinazoline-2,4-diamine
02
Targets
DHFR (Dihydrofolate reductase)
Beyond the preview
Go deeper on 5-(4-methoxyphenoxy)-2,4-quinazolinediamine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 5-(4-methoxyphenoxy)-2,4-quinazolinediamine.